Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities

Park, Hayne Cho; Kim, Do Hyoung; Yoo, Kyung Don; Kim, Yang‐Gyun; Lee, Sang‐Ho; Yoon, Hye Eun; Kim, Yon Su; Kim, Seong Nam; Kim, Myeong Sung; Jung, Yoon Chul; Kim, Yon Su; Lee, Young-Ki

doi:10.23876/j.krcp.20.046

Cited by 29 publications

(39 citation statements)

References 8 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Fortunately, no infection transmission occurred between patients. The Korean Society of Nephrology had released clinical practice guidelines for preventing COVID-19 transmission within hemodialysis facilities in 2020 [ 17 ]. The availability of a systematic management system for patients on dialysis after the COVID-19 outbreak may have contributed to the prevention of inter-patient transmission of infections.…”

Section: Discussionmentioning

confidence: 99%

Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea

Jung

Lim

Kang

et al. 2020

JCM

View full text Add to dashboard Cite

Patients with advanced chronic kidney disease (CKD) or who are on hemodialysis (HD) could have increased susceptibility to the 2019 coronavirus disease (COVID-19) given their pre-existing comorbidities, older age, compromised immune system, and regular visits to populated outpatient dialysis centers. This study included 14 consecutive patients on HD or with advanced CKD who initiated HD after being diagnosed with laboratory-confirmed COVID-19 from February to April 2020 in hospitals throughout Daegu, South Korea. The included patients, 42.9% of whom were men, had a mean age of 63.5 years. Four patients had a history of contact with a patient suffering from COVID-19. The most common symptom was cough (50.0%), followed by dyspnea (35.7%). The mean time from symptom onset to diagnosis and admission was 2.6 and 3.5 days, respectively. Patients exhibited lymphopenia and elevated inflammatory markers, including C-reactive protein and ferritin. Chest radiography findings showed pulmonary infiltration in 10 patients. All patients underwent regular HD in a negative pressure room and received antiviral agents. Four patients received mechanical ventilation and continuous renal replacement therapy at a median duration of 14.0 and 8.5 days, respectively. One patient underwent extracorporeal membrane oxygenation for three days. Among the 14 patients included, two died due to acute respiratory distress syndrome, nine were discharged from the hospital, and three remained hospitalized. Despite the high-risk conditions associated with worse outcomes, patients on HD did not exhibit extremely poor overall COVID-19 outcomes perhaps due to early diagnosis, prompt hospitalization, and antiviral therapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea

Jung

Lim

Kang

et al. 2020

JCM

View full text Add to dashboard Cite

show abstract

“…A joint committee which comprised of nephrologists from the Korean Society of Nephrology and the Korean Society of Dialysis Therapy was established. The committee announced the clinical practice guidelines for preventing transmission of COVID-19 [ 5 ]. In Daegu, an explosive increase of COVID-19 cases was reported after infection was initially identified, and 55.5% of COVID-19 patients in Korea were confirmed.…”

Section: Introductionmentioning

confidence: 99%

Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality

et al. 2020

View full text Add to dashboard Cite

Although the lungs are major targets for COVID-19 invasion, other organs—such as the kidneys—are also affected. However, the renal complications of COVID-19 are not yet well explored. This study aimed to identify the incidence of acute kidney injury (AKI) in patients with COVID-19 and to evaluate its impact on patient outcomes. This retrospective study included 704 patients with COVID-19 who were hospitalized at two hospitals in Daegu, Korea from February 19 to March 31, 2020. AKI was defined according to the serum creatinine criteria in the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. The final date of follow-up was May 1, 2020. Of the 704 patients, 28 (4.0%) developed AKI. Of the 28 patients with AKI, 15 (53.6%) were found to have AKI stage 1, 3 (10.7%) had AKI stage 2, and 10 (35.7%) had AKI stage 3. Among these patients, 12 (42.9%) recovered from AKI. In the patients with AKI, the rates of admission to intensive care unit (ICU), administration of mechanical ventilator (MV), and in-hospital mortality were significantly higher than in patients without AKI. Multivariable analysis revealed that old age (Hazard ratio [HR] = 4.668, 95% confidence interval [CI] = 1.250–17.430, p = 0.022), high neutrophil-to-lymphocyte ratio (HR = 1.167, 95% CI = 1.078–1.264, p < 0.001), elevated creatinine kinase (HR = 1.002, 95% CI = 1.001–1.004, p = 0.007), and severe AKI (HR = 12.199, 95% CI = 4.235–35.141, p < 0.001) were independent risk factors for in-hospital mortality. The Kaplan-Meier curves showed that the cumulative survival rate was lowest in the AKI stage 3 group (p < 0.001). In conclusion, the incidence of AKI in patients with COVID-19 was 4.0%. Severe AKI was associated with in-hospital death.

show abstract

“…As the worldwide coronavirus disease 2019 (COVID-19) pandemic continues, morbidity and mortality have increased 1 2) . The pathogen responsible for COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel coronavirus belonging to the betacoronavirus genus and causes severe pneumonia in humans 2 3) . There have been many studies to research SARS-CoV-2 around the world, and new information about this virus is continuously being updated.…”

Section: Introductionmentioning

confidence: 99%

Hypertension and Electrolyte Disorders in Patients with COVID-19

Lim

Jung

Choi

et al. 2020

Electrolyte Blood Press

View full text Add to dashboard Cite

Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities

Cited by 29 publications

References 8 publications

Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea

Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea

Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality

Hypertension and Electrolyte Disorders in Patients with COVID-19

Contact Info

Product

Resources

About